AthGene

About:

AthGene is the world's first subscription-based genetics platform.

Twitter/X: AthGene

Top Investors: Seed Capital, Kjøller, Magnus Kjøller

Description:

AthGene has the world's first subscription-based genetics platform. By signing up you can unlock new categories on a weekly basis. Thereby, AthGene makes it possible for everyone to learn more about their body's unique genetic makeup. This information is relevant for fitness enthusiasts, athletes, as well as anyone else who is simply curious as to how their genes impacts their body's natural abilities.

Total Funding Amount:

4M DKK

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Copenhagen, Hovedstaden, Denmark

Founded Date:

2015-04-01

Contact Email:

info(AT)athgene.com

Founders:

Sebastian Thomsen, Theis Thorn, Yusufa Sey

Number of Employees:

11-50

Last Funding Date:

2017-03-16

IPO Status:

Private

Industries: